Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 34.53
+0.38 (1.11%)
Apr 8, 2026, 3:04 PM CST
SHE:000513 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Net Income | 2,023 | 2,061 | 1,954 | 1,909 | 1,776 |
Depreciation & Amortization | 568.75 | 575.14 | 840.32 | 652.32 | 445.27 |
Other Amortization | 57.73 | 144.53 | 47.58 | 33.31 | 26.07 |
Loss (Gain) From Sale of Assets | 3.21 | -38.14 | 2.03 | 12.97 | -7.03 |
Asset Writedown & Restructuring Costs | 70.67 | 12.8 | 0.57 | 0.16 | 6.15 |
Loss (Gain) From Sale of Investments | -58.14 | -12.27 | -37.44 | 29.6 | -71.95 |
Provision & Write-off of Bad Debts | -0.5 | 4.64 | 13.45 | 4.83 | 7.4 |
Other Operating Activities | 490.65 | 419.62 | 349.26 | 204.44 | 341.21 |
Change in Accounts Receivable | -279.1 | 270.24 | 466.29 | -660.45 | -664.68 |
Change in Inventory | 398.57 | -13.32 | -334.42 | -498.57 | -232.01 |
Change in Accounts Payable | -58.99 | -388.51 | -115.71 | 1,035 | 228.02 |
Change in Other Net Operating Assets | - | -3.34 | 76.73 | 47.32 | 32.73 |
Operating Cash Flow | 3,145 | 2,979 | 3,249 | 2,773 | 1,902 |
Operating Cash Flow Growth | 5.58% | -8.31% | 17.18% | 45.75% | -11.96% |
Capital Expenditures | -574.14 | -570.16 | -820.45 | -940.15 | -1,309 |
Sale of Property, Plant & Equipment | 1.99 | 1.58 | 14.46 | 2.96 | 9.09 |
Cash Acquisitions | - | - | -22.46 | - | - |
Divestitures | - | - | - | - | 3.31 |
Investment in Securities | -1,360 | -103.05 | -1.59 | -399.18 | -675.7 |
Other Investing Activities | -1,829 | 11.3 | 121.67 | 106.5 | 95.5 |
Investing Cash Flow | -3,761 | -660.33 | -708.37 | -1,230 | -1,877 |
Long-Term Debt Issued | 3,910 | 5,866 | 3,658 | 3,714 | 2,800 |
Total Debt Issued | 3,910 | 5,866 | 3,658 | 3,714 | 2,800 |
Long-Term Debt Repaid | -4,865 | -6,048 | -3,149 | -2,827 | -2,055 |
Net Debt Issued (Repaid) | -954.73 | -182.86 | 508.29 | 886.02 | 744.96 |
Issuance of Common Stock | - | 208.55 | - | 42.25 | 202.56 |
Repurchase of Common Stock | -579.87 | -858.56 | -346.15 | -56.04 | -238.18 |
Common Dividends Paid | -1,033 | -1,340 | -1,590 | -1,591 | -1,257 |
Other Financing Activities | -95.72 | -312.71 | -229.5 | -1.51 | -266.98 |
Financing Cash Flow | -2,663 | -2,486 | -1,657 | -720.36 | -815.02 |
Foreign Exchange Rate Adjustments | -98.11 | 8.81 | 20.04 | 124.89 | -37.15 |
Net Cash Flow | -3,377 | -158.55 | 903.72 | 947.33 | -826.74 |
Free Cash Flow | 2,571 | 2,409 | 2,428 | 1,833 | 593.23 |
Free Cash Flow Growth | 6.73% | -0.81% | 32.52% | 208.91% | -60.81% |
Free Cash Flow Margin | 21.39% | 20.39% | 19.54% | 14.51% | 4.92% |
Free Cash Flow Per Share | 2.88 | 2.62 | 2.61 | 1.96 | 0.63 |
Cash Income Tax Paid | 1,397 | 1,454 | 1,321 | 1,025 | 1,236 |
Levered Free Cash Flow | 1,769 | 1,586 | 1,694 | 706.85 | -6.29 |
Unlevered Free Cash Flow | 1,805 | 1,641 | 1,758 | 767.81 | 46.21 |
Change in Working Capital | -10.59 | -188.56 | 79.51 | -74.36 | -620.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.